Innospec Stock Forecast, Price & News

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Innospec in the last year. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" Innospec stock.
View analyst ratings for Innospec or view top-rated stocks.

2 Wall Street analysts have issued twelve-month target prices for Innospec's stock. Their IOSP stock forecasts range from $110.00 to $110.00. On average, they anticipate Innospec's share price to reach $110.00 in the next year. This suggests a possible upside of 17.5% from the stock's current price.
View analysts' price targets for Innospec or view top-rated stocks among Wall Street analysts.

Innospec's stock was trading at $90.34 at the start of the year. Since then, IOSP shares have increased by 3.6% and is now trading at $93.63.
View the best growth stocks for 2022 here.

Innospec is scheduled to release its next quarterly earnings announcement on Tuesday, August 2nd 2022.
View our earnings forecast for Innospec.

Innospec Inc. (NASDAQ:IOSP) announced its quarterly earnings data on Tuesday, May, 3rd. The specialty chemicals company reported $1.53 EPS for the quarter, topping analysts' consensus estimates of $1.18 by $0.35. The specialty chemicals company had revenue of $472.40 million for the quarter, compared to analysts' expectations of $397.67 million. Innospec had a net margin of 6.57% and a trailing twelve-month return on equity of 12.87%. Innospec's revenue for the quarter was up 39.1% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.06 EPS.
View Innospec's earnings history.

Innospec announced a Semi-Annual dividend on Tuesday, May 3rd. Stockholders of record on Tuesday, May 17th will be given a dividend of $0.63 per share on Thursday, May 26th. This represents a dividend yield of 1.3%. The ex-dividend date of this dividend is Monday, May 16th. This is a positive change from Innospec's previous Semi-Annual dividend of $0.59.
View Innospec's dividend history.

Innospec(NASDAQ:IOSP) pays an annual dividend of $1.26 per share and currently has a dividend yield of 1.38%. Innospec has been increasing its dividend for 2 consecutive year(s), indicating that it does not yet have a strong track record of dividend growth. The dividend payout ratio of Innospec is 29.58%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Innospec will have a dividend payout ratio of 19.94% next year. This indicates that Innospec will be able to sustain or increase its dividend.
View Innospec's dividend history.

12 employees have rated Innospec CEO Patrick S. Williams on Glassdoor.com. Patrick S. Williams has an approval rating of 96% among Innospec's employees. This puts Patrick S. Williams in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Some companies that are related to Innospec include Sherwin-Williams (SHW), Ecolab (ECL), International Flavors & Fragrances (IFF), Albemarle (ALB), Celanese (CE), RPM International (RPM), Ashland Global (ASH), Balchem (BCPC), Sensient Technologies (SXT), H.B. Fuller (FUL), NewMarket (NEU), Quaker Chemical (KWR), Stepan (SCL), Minerals Technologies (MTX) and Chase (CCF).
View all of IOSP's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Innospec investors own include NVIDIA (NVDA), Altria Group (MO), Ecolab (ECL), Eastman Chemical (EMN), Corning (GLW), Realty Income (O), Pfizer (PFE), Sherwin-Williams (SHW), Weyerhaeuser (WY) and Applied Materials (AMAT).

Innospec trades on the NASDAQ under the ticker symbol "IOSP."

Innospec's stock is owned by a variety of retail and institutional investors. Top institutional investors include BlackRock Inc. (17.17%), Vanguard Group Inc. (11.14%), Royce & Associates LP (4.81%), Dimensional Fund Advisors LP (4.71%), Champlain Investment Partners LLC (3.83%) and State Street Corp (3.61%). Company insiders that own Innospec stock include Brian Watt, Catherine Hessner, David Landless, Hugh Aldous, Ian Cleminson, Ian Malcolm Mcrobbie, Milton C Blackmore, Patrick Williams and Philip John Boon.
View institutional ownership trends for Innospec.

IOSP stock was sold by a variety of institutional investors in the last quarter, including Royce & Associates LP, Royal Bank of Canada, Mondrian Investment Partners LTD, Champlain Investment Partners LLC, Westwood Holdings Group Inc., Aviva PLC, Skandinaviska Enskilda Banken AB publ , and Northern Trust Corp. Company insiders that have sold Innospec company stock in the last two years include Brian Watt, David Landless, Ian Cleminson, Ian Malcolm Mcrobbie, Milton C Blackmore, Patrick Williams, and Philip John Boon.
View insider buying and selling activity for Innospec or view top insider-selling stocks.

IOSP stock was bought by a variety of institutional investors in the last quarter, including Victory Capital Management Inc., Leeward Investments LLC MA, Goldman Sachs Group Inc., Vanguard Group Inc., Wasatch Advisors Inc., State Street Corp, Qube Research & Technologies Ltd, and Raymond James & Associates.
View insider buying and selling activity for Innospec or or view top insider-buying stocks.

Shares of IOSP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of IOSP stock can currently be purchased for approximately $93.63.

Innospec (NASDAQ:IOSP) has a market capitalization of $2.32 billion and generates $1.48 billion in revenue each year. The specialty chemicals company earns $93.10 million in net income (profit) each year or $4.26 on an earnings per share basis.

Innospec employs 1,900 workers across the globe.

Innospec was founded in 1938.

Innospec's mailing address is 8310 SOUTH VALLEY HIGHWAY SUITE 350, ENGLEWOOD CO, 80112. The official website for Innospec is www.innospecinc.com. The specialty chemicals company can be reached via phone at (303) 792-5554, via email at [email protected], or via fax at 303-792-5668.